MoneyWorks4Me

Emmessar Biotech & Nutrition informs about board meeting outcome

09 Dec 2023 Evaluate

Emmessar Biotech & Nutrition has informed that the Board of Directors at their meeting approved and took on record the Un-Audited Financial Results for the second quarter ended September 30, 2023.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..